Global H1N1 Vaccines Market 2016-2020

Table of Contents

PART 01: Executive summary

• Highlights

PART 02: Scope of  the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Disease overview

• Understanding the disease
• Causes of H1N1 diseases
• Signs and symptoms

PART 06: Regulatory scenario of vaccines

PART 07: WHO recommendations for H1N1 vaccines

• Key H1N1 virus vaccines for 2014-2015 season in US
• H1N1 virus vaccines approved in EU

PART 08: Reimbursement for influenza vaccines in US

• The US healthcare reform
• Reimbursement for influenza vaccines

PART 09: Reimbursement for influenza vaccines in other major countries

• UK
• Germany
• Spain
• Italy
• France
• Japan

PART 10: Market landscape

• Global human vaccines market
• Global H1N1 vaccines market
• Five forces analysis

PART 11: Market segmentation  by ROA

• Intramuscular vaccines
• Intranasal vaccines
• Intradermal vaccines

PART 12: Geographical segmentation

• Global H1N1 vaccines market by geographical segmentation 2015-2020
• H1N1 vaccines market in Americas
• H1N1 vaccines market in EMEA
• H1N1 vaccines market in APAC

PART 13: Market drivers

• Global action plan for influenza vaccines
• Increase in R&D
• Inclusion in NIP
• Rise in awareness

PART 14: Impact of drivers

PART 15: Market challenges

• Antigenic drift and shift of H1N1v virus
• Vaccine storage and handling issues
• Stringent regulatory guidelines
• Emergence of local players

PART 16: Impact of drivers and challenges

PART 17: Market trends

• Universal influenza vaccine
• Emergence of quadrivalent vaccines
• Increase in strategic alliances and M&A
• Improved understanding of immunology

PART 18: Vendor landscape

• Competitive scenario
• Market share analysis 2015
• Sanofi
• GSK
• AstraZeneca
• CSL
• Other prominent vendors

PART 19: Appendix

• List of abbreviations

PART 20: Explore Technavio